Emergence of a new opportunistic pathogen, Candida lusitaniae.
AUTOR(ES)
Blinkhorn, R J
RESUMO
Candida lusitaniae has been an infrequently reported opportunistic pathogen. Most previously reported cases of serious infection caused by this organism have proven fatal and were associated with amphotericin resistance of the organism. We report two patients with hematologic malignancies undergoing cytotoxic chemotherapy who developed fungemia with this organism while they were granulocytopenic. The organisms isolated from each patient were fully susceptible and were treated successfully with amphotericin B. When isolated from an immunocompromised host, C. lusitaniae should be considered an opportunistic pathogen and undergo antifungal susceptibility testing. Amphotericin B should be considered the drug of choice, but a poor clinical response may be indicative of a resistant isolate.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=267283Documentos Relacionados
- Epidemiology of nosocomial acquisition of Candida lusitaniae.
- Torulopsis candida, a new opportunistic pathogen.
- Strain delineation and epidemiology of Candida (Clavispora) lusitaniae.
- Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.
- Comparison of four DNA-based methods for strain delineation of Candida lusitaniae.